Form 4: DarioHealth Director Adam Stern Awarded 20,000 Shares

DarioHealth Corp. Director Adam K. Stern received an award of 20,000 restricted common shares, vesting in two years.

Summary

• Adam K. Stern, a Director of DarioHealth Corp. (DRIO), acquired 20,000 shares of Common Stock on September 11, 2025.
• The acquisition was a restricted share award with a price of $0 per share.
• These restricted shares are scheduled to vest on the last day of the second-year anniversary after the grant date.
• Following this transaction, Adam K. Stern directly beneficially owns 29,717 shares of Common Stock.
• Additionally, Adam K. Stern indirectly beneficially owns 6,146 shares of Common Stock and 123,763 shares of Series-C Preferred Stock through AKS Family Partners L.P.
• The reported beneficial ownership numbers reflect a 20-for-1 reverse stock split that was effected on August 28, 2025.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as a director is increasing their stake, aligning interests with shareholders, which is generally viewed favorably. However, the filing itself is purely transactional and does not contain performance data.

Positives

• A Director receiving a significant restricted share award (20,000 shares) can signal confidence in the company's future and aligns management's interests with shareholders.
• The award is granted at a $0 price, indicating it is compensation or an incentive, which is common for restricted stock units.

Negatives

• No explicit negatives are detailed in this Form 4 filing.

Risks

• No specific risks are explicitly mentioned in this Form 4 filing.

Future Outlook

The restricted share award is set to vest on the last day of the second-year anniversary after the grant date, indicating a future milestone for the reporting person's ownership.

Industry Context

This filing is a standard disclosure of an insider transaction and does not provide broader industry context. However, restricted stock awards are a common form of executive and director compensation in the healthcare technology sector, aiming to incentivize long-term performance.

Related Party Transactions

• Adam K. Stern's indirect beneficial ownership of Common Stock and Series-C Preferred Stock through AKS Family Partners L.P. represents a related party holding.

Stakeholder Impact

• Shareholders: The award of restricted shares to a director can be seen as a positive signal, aligning the director's long-term interests with those of the shareholders.
• Management: The award serves as an incentive for the director, potentially motivating continued engagement and performance.

Next Steps

• The restricted share award will vest on the last day of the second-year anniversary after the grant date.

Key Dates

Keywords

DarioHealth Corp., DRIO, Adam Stern, Insider Transaction, Restricted Stock Award, Director Compensation, Beneficial Ownership, Reverse Stock Split